Alibaba Health Information Technology Limited (ALBBY) Research

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Open Alibaba Health Information Technology Limited (ALBBY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.